ulmonary arterial hypertension (PAH) is a rare disease of poor prognosis. Recently, continuous intravenous epoprostenol (EPO) was introduced as a treatment for PAH with the consequent improvement of the patients' quality of life. 1 Although therapy with EPO improves the patients' exercise capacity and prognosis, various complications related to the central venous catheters arise during long-term treatment with EPO. 2,3 Among them, catheter-related infection is a serious problem, because the infections aggravate the primary disease.
PAH receiving continuous therapy with EPO were referred to the National Hospital Organization Okayama Medical Center and to the Department of Cardiovascular Medicine of Okayama University. PAH was either idiopathic (19 patients) or caused by a connective tissue disease (1 patient) and was defined as PAH based on a mean pulmonary arterial pressure ≥25 mmHg at rest, pulmonary capillary wedge pressure ≤15 mmHg and a pulmonary vascular resistance of ≥240 dyne·s·cm -5 . All patients underwent an infusion of EPO via a central venous catheter (Hickman; CR Bard, Inc, NJ, USA). The trained physicians inserted the catheters into the subclavian vein in the angiography room. Before the insertion, the skin was disinfected with 10% povidoneiodine or chlorhexidine gluconate. The physicians performed a thorough hand scrub, wore sterile gloves, gown, cap, and mask, and used large sterile drapes. In 11 patients (4 men and 7 women) who were started on continuous therapy with EPO before August 2002, we used the nonclosed hub system. And in 9 patients (2 men and 7 women) who were started on continuous therapy with EPO after January 2003, we used the closed hub system. In addition, in 4 patients (all women) who had suffered catheter-related infections with the non-closed hub system, this was changed to the closed hub system after March 2003. Patients were discharged from hospital after they were instructed on the care and maintenance of the catheter. All patients were monitored every 1-4 months. During the intervals, their private physicians were in the charge of the catheter care and maintenance. All patients were not treated with oral steroids. And there were no patients with immunodeficiency. The local institutional review boards approved the protocol of this study. All participating patients provided informed consent to participate in the study.
Care and Maintenance of the Catheter
The administration of EPO required a daily mixing of the drug in both systems. At first in the non-closed hub system, patients had to fill a backup infusion pump reservoir with EPO under sterile conditions. Then, the patients had to disconnect the catheter from the infusing pump and quickly connect it to the newly filled pump. Thus, the patients' extension tube connected to their central venous catheter, which was 'opened' every day.
In the closed hub system, the EPO was refilled from the infusion port in the medication baggage under sterile conditions. All the patients had to change the medication baggage and the extension tube every 3 days. Because the central venous catheter was closed by the I-plug, the catheter was never 'opened' while they were at home. A physician changed the I-plug using a sterile procedure when the patient visited the outpatient clinic every month. The tube and central venous catheter was reconnected using sterile procedures, without the use of a saline solution or heparin.
A sterile dry gauze or semi-permeable dressing was used to seal the catheter insertion site under sterile conditions every day. The skin around the catheter insertion site was disinfected with povidone-iodine or chlorhexidine gluconate at the time the dressing was changed. This dressing regimen was not changed over time. Physicians and nurses were instructed on the care and maintenance of the patient catheters. And patients were instructed to ask a nurse and/or a physician for an evaluation immediately if they noted erythema, edema, tenderness and/or a persistent discharge at the catheter insertion site or generalized low-grade fever.
Definitions of Catheter-Related Infections
When the patients suspected a catheter-related infection, they were instructed to immediately visit our hospital or a private physician. When the private physician diagnosed a catheter-related infection, he/she must have referred the patient to our hospital for admission or prescribed antibiotics. In fact, patients were admitted to our hospital when catheter-related infections did not improve after physician treatment. At the hospital, a chest radiograph was taken, and blood and urine examinations were carried out. We diagnosed a patient as having a catheter-related infection according to the 2002 CDC recommendations. 12 Catheterrelated bloodstream infections (CRBSI) was defined as at least 1 positive blood culture obtained from a peripheral vein, in a patient with clinical manifestations of infections (ie, fever, chills, and/or hypotension) and if there was no apparent source for bloodstream infection except for the catheter. Tunnel infection was defined as erythema, edema, tenderness, or drainage from the exit site. If necessary, we removed the Hickman catheter and cultured the catheter tip and pus from the insertion site. 
Statistical Analysis
Results are reported as the mean ± standard deviation. Infection rates are reported as per 1,000 patient days. The cumulative risk of developing a catheter-related infection in the 2 groups as a function of the duration of catheterization was estimated according to the Kaplan -Meier method and compared with the use of the log rank test.
Results
The patient characteristics are shown in Table 1 . The patients' age ranged from 15 to 58 years (mean age 31.3 years). The total number of catheter days was 5,894 days in the non-closed hub system group and 8,838 days in the closed hub system group. The duration of catheter indwelling was 281-1306 days, with an average of 536±367 days in the non-closed hub system group and 50-1,386 days, with an average of 680±370 days in the closed hub system group.
In the non-closed hub system group, 9 patients developed a total of 21 catheter-related infections during the study period ( tunnel infections and 6 patients (7 catheter infections) had CRBSI. Five patients developed both types of infections.
In the closed hub system group, 5 patients developed a total of 6 catheter-related infections during the study period ( Table 2) . Four patients (4 catheter infections) had tunnel infections and 1 (2 catheter infections) had CRBSI. Two of the patients who developed tunnel infections had previously used the non-closed hub system, and one of them had suffered repeated tunnel infections (5 catheter infections) with the non-closed hub system.
All patients were admitted to either of our 2 centers. In the patients with tunnel infection, the catheter had to be removed as part of the treatment and they were administered antibiotics intravenously at least once a week, except for 1 patient. In 1 patient, treatment with just oral antibiotics was sufficient to eradicate the infection.
The etiologic organism was identified in at least one cultured specimen in 13 of the 27 clinical episodes of infections. The organisms isolated are listed in Table 3 . Methicillin-sensitive staphylococcus aureus (MSSA) was the most frequent isolate in both groups. In the non-closed hub system, bacterial cultures were negative in 7 of the 21 clinical infections.
The overall catheter-related infection rate for our patients was 1.53 per 1,000 catheter days in the non-closed hub system group vs 0.45 per 1,000 catheter days in the closed hub system group. The CRBSI rate was 0.89 per 1,000 catheter days in the non-closed hub system group vs 0.10 per 1,000 catheter days in the closed hub system group. The tunnel infection rate was 0.87 per 1,000 catheter days in the non-closed hub system group vs 0.33 per 1,000 catheter days in the closed hub system group.
Kaplan -Meier estimates of the overall risk for catheterrelated infections showed a significant difference between the non-closed hub system and the closed hub system (Fig 2, p=0.029 ). Furthermore, Kaplan -Meier estimates of the risk for CRBSI showed a significant difference between the non-closed hub system and the closed hub system (Fig 3, p=0.043 ). However, Kaplan -Meier estimates of the risk for tunnel infections showed no difference between the 2 groups (Fig 4, p=0.699) .
None of the patients died as a direct consequence of a catheter-related infection during the study period.
Discussion
In the present study, the overall incidence of catheterrelated infections and CRBSI was significantly decreased with the closed hub system. Furthermore, the incidence of CRBSI was extremely low in comparison to that found in a previous study. 7 Recently, the use of continuous infusion therapies at home, for example, total parenteral nutrition, has remarkably increased. This type of therapy has contributed not only to an increase in therapeutic options but also in terms of improving patients' quality of life. However, various problems associated with the management of this therapy still persist. Catheter-related infections, one of the most serious problems, can aggravate the primary disease and worse, might result in death. Catheter-related infections associated with the therapy have been evaluated with regard to various diseases. [13] [14] [15] [16] In the present study, catheter-related infections were divided into 2 groups according to the 2002 CDC recommendations. This difference can be explained by the path- ways of bacterial invasion. CRBSI could be caused by bacterial invasion through the catheter connection. Tunnel infection could be caused by direct bacterial invasion through the catheter insertion site. To prevent catheterrelated infections, we need to identify which pathway of bacterial invasion was predominant in an individual case.
Previously, it was considered that direct bacterial invasion through the catheter insertion site was the main cause of catheter-related infections. 17, 18 To prevent direct bacterial invasion, it was thought that the catheter insertion site had to be cleaned and the subcutaneous tunnel had to be long. However, it was reported that the results of bacterial culture from the catheter insertion site did not necessarily coincide with those of blood and catheter tip cultures. 19, 20 In addition, the use of long subcutaneous tunnels failed to decrease the frequency of catheter-related infections. 21, 22 As a result, attention has now focused on bacterial invasion through the catheter connection. Sitges-Serra et al evaluated the possibility of bacterial contamination at the catheter connection and postulated the "hub hypothesis". 8 They reported that the hub of a catheter was the most important source of catheter-related infections. 9 This hypothesis has been supported by several studies. [23] [24] [25] [26] Consequently, we adopted the closed hub system for the catheter connection in our patients. The system we used simplifies catheter care and infusion line use compared with the non-closed hub system. Bacterial contamination can be minimized with this system because the catheter connection is not open to air during the change of the infusion line except at the monthly change of the I-plug in the clinic. The effectiveness of this system in reducing CRBSI was already reported in patients with other diseases. 10 In the present study, we showed that we could significantly decrease CRBSI by using the closed hub system in patients with PAH receiving EPO.
As for microorganisms causing catheter infections, we found that MSSA was the most frequent cause of infection, which is in agreement with the results of a previous study involving patients with PAH. 7 In that study, micrococcus spp was the second most common etiologic agent. The clinical syndrome of micrococcal catheter infection presented as generalized weakness and fatigue with or without fever. 7 Although this symptom was common in the case of CRBSI with a non-closed hub system, cultures were positive in 1 patient. This could be because of micrococcus spp might have been present; this was ignored as a possible cause in our institute until 2003. 27 Although we could decrease the overall occurrence of catheter-related infections by reducing CRBSI, approximately 50% of patients still experienced catheter-related infections during 3 years. Most of the catheter-related infections were of the tunnel type and thus it is important to focus on the prevention of tunnel infections in the future.
When a patient develops a catheter-related infection, the clinician must treat it as early as possible. However, early detection of catheter-related infections is difficult. Thus, when a patient receiving EPO starts to complain of constitutional symptoms for no apparent reason, clinicians should suspect the possibility of catheter-related infections and carry out a thorough investigation to rule out this possibility.
This study has several limitations. This is an observational and not a prospective study. We might have underestimated the true incidence of catheter-related infections. If the catheter infection was slight, clinicians might have been unaware of it. Clinicians treat catheter-related infections with antibiotics based on the diagnosis of other infections.
Conclusions
The present study demonstrated that the use of the closed hub system reduced the overall occurrence of catheterrelated infections in patients with PAH receiving continuous therapy with EPO at home. Furthermore, the risk of CRBSI was significantly decreased with this system. Besides, the incidence of CRBSI was low compared with another study involving patients with PAH receiving continuous therapy with EPO.
